Ankush Banerjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ankush Banerjee has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Myles W. Smith
UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390, United States
2 shared publications Alexander A. Busse
Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas 75390, USA
1 shared publicationArani Datta
Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas 75390, USA
1 shared publicationBruce A. Posner
Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas 75390, USA
1 shared publicationDawn M. Wetzel
Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas 75390, USA
1 shared publication- Gabriel N. Morais
Oberlin College, Department of Chemistry and Biochemistry, Oberlin, Ohio 44074, USA
1 shared publication
Latest Publications
- 30 October 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (48) , 9413-9425
Synthesis of the 5/5-spiroindimicin alkaloids: development of a general synthetic approach and biological investigations
We describe the development of a unified synthetic strategy for the preparation of all known 5/5-spirocyclic spiroindimicin (SPM) alkaloids, namely spiroindimicins B–G. The present synthetic route relies on four fundamental transformations: Grignard-based fragment coupling between halogenated pyrrolemetal and isatin partners, Suzuki coupling to generate a triaryl scaffold encompassing all requisite skeletal atoms of the natural products, Lewis acid-mediated spirocyclization to construct the 5/5-spirocyclic core, and chemoselective lactam reduction. The developed syntheses are step-economic (6–7 steps from commercial materials), scalable, and amenable to analogue synthesis. Preliminary investigations into a catalytic asymmetric spirocyclization towards an enantioselective SPM synthesis are also described. Further studies of the antiparasitic properties of this class have revealed promising activity against T. brucei for certain congeners. Together with our prior approach to the 6/5-family members, our work constitutes a synthetic solution to all known spiroindimicin natural products.
- 30 October 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (48) , 9413-9425
Synthesis of the 5/5-spiroindimicin alkaloids: development of a general synthetic approach and biological investigations
We describe the development of a unified synthetic strategy for the preparation of all known 5/5-spirocyclic spiroindimicin (SPM) alkaloids, namely spiroindimicins B–G. The present synthetic route relies on four fundamental transformations: Grignard-based fragment coupling between halogenated pyrrolemetal and isatin partners, Suzuki coupling to generate a triaryl scaffold encompassing all requisite skeletal atoms of the natural products, Lewis acid-mediated spirocyclization to construct the 5/5-spirocyclic core, and chemoselective lactam reduction. The developed syntheses are step-economic (6–7 steps from commercial materials), scalable, and amenable to analogue synthesis. Preliminary investigations into a catalytic asymmetric spirocyclization towards an enantioselective SPM synthesis are also described. Further studies of the antiparasitic properties of this class have revealed promising activity against T. brucei for certain congeners. Together with our prior approach to the 6/5-family members, our work constitutes a synthetic solution to all known spiroindimicin natural products.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 22047-22055
Total Synthesis of (−)-Rauvomine B via a Strain-Promoted Intramolecular Cyclopropanation
We describe the first total synthesis of the unusual cyclopropane-containing indole alkaloid (-)-rauvomine B via a strategy centered upon intramolecular cyclopropanation of a tetracyclic N-sulfonyltriazole. Preparation of this precursor evolved through two generations of synthesis, with the ultimately successful route involving a palladium-catalyzed stereospecific allylic amination, a cis-selective Pictet-Spengler reaction, and ring-closing metathesis as important bond-forming reactions. The key cyclopropanation step was found to be highly dependent on the structure and conformational strain of the indoloquinolizidine N-sulfonyltriazole precursor, the origins of which are explored computationally through DFT studies. Overall, our synthesis proceeds in 11 total steps and 2.4% yield from commercial materials.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 22047-22055
Total Synthesis of (−)-Rauvomine B via a Strain-Promoted Intramolecular Cyclopropanation
We describe the first total synthesis of the unusual cyclopropane-containing indole alkaloid (-)-rauvomine B via a strategy centered upon intramolecular cyclopropanation of a tetracyclic N-sulfonyltriazole. Preparation of this precursor evolved through two generations of synthesis, with the ultimately successful route involving a palladium-catalyzed stereospecific allylic amination, a cis-selective Pictet-Spengler reaction, and ring-closing metathesis as important bond-forming reactions. The key cyclopropanation step was found to be highly dependent on the structure and conformational strain of the indoloquinolizidine N-sulfonyltriazole precursor, the origins of which are explored computationally through DFT studies. Overall, our synthesis proceeds in 11 total steps and 2.4% yield from commercial materials.